/Investor DB

Old College Capital — 2025 Investments

4 investments dated 2025 · listed companies and verified rows first · show all

Black Bull Biocharblackbullbiochar.cominDec 2025

Black Bull Biochar develops a platform to enable carbon removal at scale through biochar production.

AgTechCircular EconomyCleantechClimate Tech

Co-investorsTSP VenturesInnovate UK

Forth Therapeuticsforthtx.cominMar 2025

Forth Therapeutics is an Edinburgh/Cambridge-based biotech spinout from the University of Edinburgh developing precision, omics-driven therapeutics to halt or reverse fibrosis across multiple organ systems.

Co-investorsSofinnova Partners

Prothea Technologiesprothea.techApr 2025

Prothea Technologies develops fluorescence imaging and optical sensing technologies for respiratory medicine and oncology applications.

BiotechHealthtechMedical Devices

Kev(Director & Chief Scientific and Medical Officer)

Co-investorsMérieux Equity PartnersKorysEarlybird Venture Capital

Rhizocorerhizocore.comNov 2025

Rhizocore Technologies develops mycorrhizal fungal inoculum products to enhance plant growth, woodland restoration, and ecosystem resilience.

AgTechBiotechCleantechClimate TechImpact & Social GoodEdinburgh, GB

Toby Parkes(Founder)inDavid Christopher Satori(Director)Jack Hooper(Chief Operating Officer)in

BoardDaniel Fitzgerald(Director)

Co-investorsCollaborative FundDeep Science VenturesGrosvenor EstateNucleus CapitalScottish Enterprise

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.